Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Tourangeau Greg
Principal Accounting Officer at Fulcrum Therapeutics. Filing since 10 May 2023.
CIK 0001916566
Company
Date
Role
Action
Shares
Amount
Of holding
FULC
Fulcrum Therapeutics, Inc.
8 May 2025
Principal Accounting Officer
Sold at will
498
$2.52K
3.4%
FULC
Fulcrum Therapeutics, Inc.
7 May 2024
Principal Accounting Officer
Sold at will
236
$1.83K
2.0%
FULC
Fulcrum Therapeutics, Inc.
8 Mar 2024
Vice President, Finance
Sold at will
4,884
$57.22K
29.3%
FULC
Fulcrum Therapeutics, Inc.
10 May 2023
Principal Accounting Officer
Sold at will
210
$695.10
1.3%
4 decisions on file.
